The findings suggest that keeping a close watch for signs of anxiety, depression and other difficulties and educating the child’s peers about their condition may be necessary for this age group.
Three in five of the poorest, sickest residents in L.A. County opted out of a managed health care program meant to improve their access to health services.
The five-year, $11.4 million grant will help to advance work in prevention, detection and treatment. UCLA's program is one of only five brain cancer programs nationwide to receive this national recognition.
The results bolster the argument for making cognitive behavioral therapy more widely available for treating the disorder, which affects more than one in 50 people in the U.S.
The voluntary service announced by Chancellor Gene Block will eventually be made available to the entire campus community, including those receiving care through UCLA Health.
The system is made of inexpensive components, including an image sensor chip that costs just a few dollars apiece and is like the ones used in mobile phone cameras.
UCLA researchers intend to develop devices to help patients easily conduct their own health screenings and help doctors be aware of their patients’ long-term risks.
The alliance of five UC medical centers will conduct clinical trials and study precision medicine, population health science, best practices in harnessing big data to improve health and political engagement for public benefit.
Dr. Jonathan Fielding summarizes a host of recent findings showing how a healthful diet, regular physical activity and proper amounts of sleep affect cognitive health.
The combination therapy could provide an alternative for people whose tumors don’t respond to other treatments, and it’s being tested for head, neck and colon cancers.
The finding that heart failure is linked to how DNA is packaged within heart cells represents a new way to think about the development of heart disease and its treatment.
Using traditional medical imaging processes the inflammation that sometimes results from immunotherapies can resemble neurological decline and tumor growth.